The Minister of Enterprises and Made in Italy, Adolfo Urso, in his speech at the Assembly, recalled that "at the beginning of the legislature, with the Minister of Health Schillaci, we decided to set up the pharma and biotech table here, convinced that it is important for the development of our industrial policy. This assembly demonstrates it: yours is an important industry in the country, it is growing in the EU more than the rest of the economy, it is among the most productive sectors and generates the most added value and increasingly invests in research and training. The Government is very committed at the European level to support the requests of our industry. The biotech act, currently being implemented, should serve to facilitate the activities of companies in research and investments, as well as to promote a better use of AI in drug development. The European phase is a decisive one in which our contribution is to bring the needs of the Italian system into one of the most developing sectors. In our White Paper, the Made in Italy 2030 industrial policy document, we aimed to highlight the needs of the Italian system, with biotech and health indicated among those that are giving us the greatest satisfaction." #biotecnologie #innovazione #MadeinItaly (translated)


